Actinium-225 - Global Industry Market Analysis Report 2020-2031

Actinium-225, as a radioactive isotope that has attracted much attention in the field of modern nuclear medicine, has unique physical and chemical properties. In the periodic table, it belongs to the actinide series, with atomic number 89 and a half-life of about 10 days. This relatively moderate half-life provides an operating time window for its medical applications.

From the perspective of medical applications, the outstanding advantage of Actinium-225 lies in the alpha particles it emits. Alpha particles have strong ionization ability, which means that they can release a large amount of energy in a short distance and have a strong destructive effect on the cells they come into contact with. At the same time, the range of alpha particles is extremely short, usually only within a few microns. This characteristic makes Actinium-225 extremely accurate in cancer treatment. For example, Actinium-225 is combined with specific monoclonal antibodies to form targeted radioactive drugs. Monoclonal antibodies can accurately identify specific antigens on the surface of tumor cells, like accurately guided missiles, carrying Actinium-225 to the vicinity of tumor cells. Subsequently, the alpha particles emitted by Actinium-225 release energy within a very short distance, efficiently destroying the DNA of tumor cells, thereby achieving the purpose of inhibiting tumor growth or even eliminating tumors. Compared with traditional chemotherapy and radiotherapy, this targeted radiotherapy greatly reduces the damage to surrounding healthy tissues, greatly improving the effect of cancer treatment and the quality of life of patients.

From the perspective of market prospects, Actinium-225 has shown great potential. The global incidence of cancer continues to rise. According to data from the World Health Organization (WHO), there are tens of millions of new cancer cases each year, and cancer has become one of the major diseases threatening human health. In this context, the demand for precision medicine is becoming more urgent. Actinium-225-related radiopharmaceuticals, as an important part of precision medicine, have a very considerable market demand. Although Actinium-225 currently faces problems such as limited production, complex preparation technology, and high cost, major scientific research institutions and pharmaceutical companies have increased their investment in research and development. For example, some internationally renowned pharmaceutical companies are actively exploring new production processes, trying to increase the production of Actinium-225 and reduce costs by optimizing nuclear reaction conditions and separation technology.

Looking to the future, we have a beautiful vision. We expect that in the near future, with the continuous breakthrough of technology, Actinium-225 radiopharmaceuticals will be able to achieve large-scale production and enter the medical market at a more affordable price. By then, more cancer patients, whether in developed or developing countries, will be able to benefit from this advanced treatment method. Cancer will no longer be a dreaded terminal illness, but a disease that can be effectively controlled or even cured. This will not only change the fate of countless patients and their families, but will also push the global medical and health industry to a new height, open a new chapter in the fight against cancer, and allow every life to bloom in the sunshine of health.

Report Scope

This report aims to deliver a thorough analysis of the global market for Actinium-225, offering both quantitative and qualitative insights to assist readers in formulating business growth strategies, evaluating the competitive landscape, understanding their current market position, and making well-informed decisions regarding Actinium-225.

The report is enriched with qualitative evaluations, including market drivers, challenges, Porter’s Five Forces, regulatory frameworks, consumer preferences, and ESG (Environmental, Social, and Governance) factors.

The report provides detailed classification of Actinium-225, such as type, etc.; detailed examples of Actinium-225 applications, such as application one, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report provides detailed classification of Actinium-225, such as Accelerator, Thorium-229 Decay, etc.; detailed examples of Actinium-225 applications, such as Scientific Research, Cancer Therapy, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report covers key global regions—North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa—providing granular, country-specific insights for major markets such as the United States, China, Germany, and Brazil.

The report deeply explores the competitive landscape of Actinium-225 products, details the sales, revenue, and regional layout of some of the world's leading manufacturers, and provides in-depth company profiles and contact details.

The report contains a comprehensive industry chain analysis covering raw materials, downstream customers and sales channels.

Core Chapters

Chapter One: Introduces the study scope of this report, market status, market drivers, challenges, porters five forces analysis, regulatory policy, consumer preference, market attractiveness and ESG analysis.
Chapter Two: market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Actinium-225 market sales and revenue in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter Four: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Five: Detailed analysis of Actinium-225 manufacturers competitive landscape, price, sales, revenue, market share, footprint, merger, and acquisition information, etc.
Chapter Six: Provides profiles of leading manufacturers, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction.
Chapter Seven: Analysis of industrial chain, key raw materials, customers and sales channel.
Chapter Eight: Key Takeaways and Final Conclusions
Chapter Nine: Methodology and Sources. Show more